(PDF) Prognostic Role of Β-Blocker Selectivity and Dosage

Prognostic Role of Β-Blocker Selectivity and Dosage Regimens in Heart Failure Patients. Insights From the MECKI Score Database

European Journal of Heart Failure - United States

doi 10.1002/ejhf.775

Full Text

Open PDF

Abstract

Available in full text

Date

February 24, 2017

Authors

Mariantonietta Cicoira

Romualdo Belardinelli

Pasquale Perrone Filardi

Piergiuseppe Agostoni

Publisher

Wiley

Amanote Research

Prognostic Role of Β-Blocker Selectivity and Dosage Regimens in Heart Failure Patients. Insights From the MECKI Score Database

European Journal of Heart Failure - United States

doi 10.1002/ejhf.775

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Β-Blocker Pharmacogenetics in Heart Failure

The Prognostic Role of Anemia in Heart Failure Patients

Relation of Β-Blocker Use With Frequency of Hospitalization for Heart Failure in Patients With Left Ventricular Diastolic Dysfunction (From the Heart and Soul Study)

Comments About: Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients With Heart Failure and Preserved Ejection Fraction

Dose Response Relationship of RAS Blocker and Beta-Blocker in Patients With Acute Heart Failure Syndrome: Data From the Korean Acute Hart Failure (KorAHF) Registry

Prognostic Value of Psychosocial Factors for First and Recurrent Hospitalizations and Mortality in Heart Failure Patients: Insights From the OPERA-HF Study

Prognostic Value of CA125 in Advanced Heart Failure Patients

Prognostic Factors in Patients With Congestive Heart Failure

Exploratory Analysis of Low PEACE Heart Failure Risk Score With Elevated NTproBNP: Insights From the MESA Study